BAM Logo

POCT Glucose and Ketones

[POCT Glucose and Ketones]

EPTIS factsheet 142647 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts142647 https://www.eptis.bam.de/pts142647

PT provider
PT provider Weqas Weqas
Based in United Kingdom
Remarks The measurement of capillary blood glucose using Point of Care Testing (POCT) devices is widespread across the UK, Europe and North America; with the NHS in the UK spending £165 M in primary care and £16.7 M in secondary care in 2018/ 19 on POCT devices and strips. The programme is a standard programme, as a managed service or offered as part of a contract with your POCT device supplier. Our Managed Service is designed for sites that do not have the support of a local laboratory Point of Care Department for performance oversight. A suite of reports is available, for both the end user and the POCT Co-ordinator. Ready to use plasma samples are provided in sterile dropper bottles containing both glucose and ketones. The POCT Co-ordinator (or organisational lead) can choose whether to assess each operator or each meter. One level is provided per distribution for each meter, where they can choose to receive samples monthly, bimonthly or quarterly and either sent directly to the POCT site or to the POCT Co-ordinators to distribute. The analytical range of 2.0 to 30.0 mmol/L for glucose and 0.6 to 6 mmol/l for ketone is covered over the 12 month period. Samples at key clinical targets of 2.0, 7.0, and 11.0 mmol/l for glucose and 0.6 and 3 mmol/l for ketones are covered as a minimum. Key Features: - Ready to use liquid samples in sterile dropper vials containing both glucose and ketones. - Suitable for all glucose Meters. - Sites or individual users can be assessed. - POCT Co-ordinator summary reports. - POCT Co-ordinator poor performance reports. - POCT Co-ordinators “non -return” reports. - Simple traffic light reports for end users. - Panel of samples covering the pathological range. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/poct-eqa/poct-glucose/ or contact@weqas.com
Product groups Health care / medical devices
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Red dyed serum or plasma Glucose Routine testing methods (recommended)
Ketones Routine testing methods (recommended)
Aims of the PT scheme
Target group of participants The programme is available directly from Weqas as a standard programme, as a managed service or offered as part of a contract with your POCT device supplier.
Linked to specific legislation / standards Accreditation by UKAS based on ISO/IEC 17043.
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee https://www.weqas.com/participantzone/subscription-charges/
Regularly operated Yes (Frequency: Monthly, Bimonthly or Quarterly. Samples: 1 x 0.5mL.)
Year of first operation POCT Glucose 1995, POCT Ketones 2008
Contact details of the PT provider
Provider Contact person
Unit 6, Parc Ty Glas
CF14 5DU Cardiff
United Kingdom

Phone: 44 (0) 2920 314750
Web: http://www.weqas.com http://www.weqas.com
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884
Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5